Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDRT15 pseudogene 9 (CDRT15P9) is annotated as a pseudogene in the human genome, meaning it is a DNA sequence similar to a functional gene but is generally noncoding and considered nonfunctional. There is no evidence that CDRT15P9 encodes a protein product or plays a direct biological or pathological role. Pseudogenes like CDRT15P9 arise from gene duplication or retrotransposition events and typically accumulate disabling mutations. While some pseudogenes can have regulatory functions as noncoding RNAs or compete for microRNA binding, there is no specific information supporting any functional role for CDRT15P9 in the scientific literature or genomics databases[3][5][6]. No evidence supports CDRT15P9 being a receptor, enzyme, transporter, or any typical therapeutic target class, nor is it associated with drug development or clinical biomarker applications. The entry also appears to be correct as a pseudogene, but if being considered as a therapeutic target, this is a misclassification, since pseudogenes by definition lack the usual attributes of a therapeutic target[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDRT15 pseudogene 9 (CDRT15P9).